The June 2022 edition of the Frontiers in Cardiovascular Medicine reports “Recent rodent studies have shown that melatonin acts as an anti-oxidant and is effective in suppressing heart damage mediated by pharmacologic drugs. Therefore, melatonin has been shown to have cardioprotective activity in multiple animal and human studies. Herein, we summarize the most established benefits of melatonin in the cardiovascular system with a focus on the molecular mechanisms of action.”
“Melatonin has been shown to have cardioprotective activity in multiple animal and human studies.”
Evidence for the Benefits of Melatonin in Cardiovascular Disease, Front Cardiovasc Med, June 2022.
